Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, January 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Readers on

mendeley: 106 Mendeley
citeulike: 1 CiteULike

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 33,065 followers.

@harriet87015606 Capecitabine and temozolomide (CAPTEM). I have neuroendocrine cancer. https://t.co/DL1JFlqOiB

13 Jul 2023

Reply Repost Favourite

Im Sinne der Verträglichkeit kann man sich durchaus an der @PancreasCenter „experience“ orientieren (👇🏼) und mit einer niedrigeren Capecitabine Dosierung arbeiten, ggf. Steigerung im Verlauf. https://t.co/rtSN9kUOWP

11 Aug 2021

Reply Repost Favourite

Capecitabine & temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas... http://t.co/t4A4mnZk6O

26 Nov 2013

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.